Search details
1.
Ovarian cancer mutational processes drive site-specific immune evasion.
Nature
; 612(7941): 778-786, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36517593
2.
Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 187: 80-84, 2024 May 11.
Article
in English
| MEDLINE | ID: mdl-38735143
3.
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.
Gynecol Oncol
; 186: 104-109, 2024 Apr 18.
Article
in English
| MEDLINE | ID: mdl-38640773
4.
Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.
Gynecol Oncol
; 182: 141-147, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38262237
5.
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
Gynecol Oncol
; 183: 126-132, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38493020
6.
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Int J Gynecol Cancer
; 34(4): 594-601, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38296517
7.
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer.
Int J Gynecol Cancer
; 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38514101
8.
Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies.
Cancer
; 129(13): 2004-2012, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36951509
9.
Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 169: 118-124, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36565685
10.
Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 179: 169-179, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37992548
11.
Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.
Gynecol Oncol
; 169: 85-90, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36521353
12.
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 176: 69-75, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37454565
13.
Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering Cancer Center study.
Gynecol Oncol
; 170: 46-53, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36621269
14.
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trial.
Gynecol Oncol
; 168: 100-106, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36423444
15.
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer.
Int J Gynecol Cancer
; 2023 Dec 07.
Article
in English
| MEDLINE | ID: mdl-38088180
16.
CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know-Radiology In Training.
Radiology
; 304(3): 516-526, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35608442
17.
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.
Gynecol Oncol
; 165(2): 239-247, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35292180
18.
A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
Gynecol Oncol
; 167(2): 277-282, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36064678
19.
Risk factors for financial toxicity in patients with gynecologic cancer.
Am J Obstet Gynecol
; 226(6): 817.e1-817.e9, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34902319
20.
Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary study.
Int J Gynecol Cancer
; 32(2): 159-164, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34969828